EX-FILING FEES 3 tm2418975d3_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

424(b)(7)

(Form Type)

 

Rhythm Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
effective
date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities

Fees to
Be Paid

  Equity   Common Stock, par value $0.001 per share   Rule 457(c)   3,124,995 (1)   $41.62(2)   $130,062,292   0.00014760   $19,198                

Fees

Previously

Paid

                                 
Carry Forward Securities

Carry

Forward

Securities

                           
    Total Offering Amounts       $130,062,292       $19,198                
    Total Fees Previously Paid                              
    Total Fee Offsets(3)                               
    Net Fee Due               $19,198                
                                                   

 

(1)Consists of 3,124,995 shares of common stock registered pursuant to this prospectus supplement to be offered by the selling stockholders named herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of any stock dividend, stock split, recapitalization or similar transaction. Separate consideration may or may not be received for shares of common stock that are issuable upon conversion, exercise, or exchange of other securities.

(2)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, on the basis of the average of the high and low prices for a share of the Registrant’s common stock as reported on the Nasdaq Global Market on July 5, 2024, which date is within five business days prior to the filing of this prospectus supplement.

(3)The Registrant does not have any fee offsets.